Implantation of Bone Marrow Cells to Treat Avascular Necrosis of Femoral Head (ANFH)
Control Study of Implantation of Enriched Bone Marrow Cells for the Treatment of Avascular Necrosis of Femoral Head
Sponsor: Guangdong Provincial People's Hospital
Listed as NCT01613612, this PHASE2/PHASE3 trial focuses on Avascular Necrosis of Femur Head and remains ongoing. Sponsored by Guangdong Provincial People's Hospital, it has been updated 7 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2/PHASE3
Status: Unknown Status → Unknown · Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2_PHASE3
-
Dec 2019 — Jan 2021 [monthly]
Unknown Status PHASE2_PHASE3
-
Jun 2018 — Dec 2019 [monthly]
Unknown Status PHASE2_PHASE3
▶ Show 2 earlier versions
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status PHASE2_PHASE3
Status: Enrolling By Invitation → Unknown Status
-
Jan 2017 — Feb 2017 [monthly]
Enrolling By Invitation PHASE2_PHASE3
First recorded
Mar 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Guangdong Provincial People's Hospital
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.